Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | $110,705 | 55 | 90.1% |
| Travel and Lodging | $5,929 | 20 | 4.8% |
| Food and Beverage | $5,213 | 179 | 4.2% |
| Education | $529.99 | 7 | 0.4% |
| Consulting Fee | $442.50 | 1 | 0.4% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Teva Pharmaceuticals USA, Inc. | $69,723 | 94 | $0 (2024) |
| Sunovion Pharmaceuticals Inc. | $28,719 | 31 | $0 (2020) |
| Allergan, Inc. | $23,894 | 108 | $0 (2020) |
| ABBVIE INC. | $324.80 | 25 | $0 (2023) |
| Johnson & Johnson Vision Care, Inc. | $111.72 | 1 | $0 (2019) |
| Novartis Pharmaceuticals Corporation | $18.44 | 1 | $0 (2018) |
| Otsuka America Pharmaceutical, Inc. | $16.97 | 1 | $0 (2020) |
| Supernus Pharmaceuticals, Inc. | $11.32 | 1 | $0 (2021) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $14,301 | 24 | Teva Pharmaceuticals USA, Inc. ($14,301) |
| 2023 | $13,240 | 19 | Teva Pharmaceuticals USA, Inc. ($13,132) |
| 2022 | $8,836 | 12 | Teva Pharmaceuticals USA, Inc. ($8,761) |
| 2021 | $13,307 | 27 | Teva Pharmaceuticals USA, Inc. ($13,153) |
| 2020 | $6,053 | 36 | Teva Pharmaceuticals USA, Inc. ($5,200) |
| 2019 | $17,918 | 42 | Teva Pharmaceuticals USA, Inc. ($9,082) |
| 2018 | $32,114 | 54 | Sunovion Pharmaceuticals Inc. ($14,096) |
| 2017 | $17,051 | 48 | Sunovion Pharmaceuticals Inc. ($9,798) |
All Payment Transactions
262 individual payment records from CMS Open Payments — Page 1 of 11
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/02/2024 | Teva Pharmaceuticals USA, Inc. | Austedo XR (Drug) | Food and Beverage | In-kind items and services | $16.03 | General |
| Category: Central Nervous System | ||||||
| 11/14/2024 | Teva Pharmaceuticals USA, Inc. | — | Education | In-kind items and services | $71.49 | General |
| 09/05/2024 | Teva Pharmaceuticals USA, Inc. | Austedo XR (Drug) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $2,600.00 | General |
| Category: Central Nervous System | ||||||
| 09/05/2024 | Teva Pharmaceuticals USA, Inc. | Austedo XR (Drug) | Food and Beverage | In-kind items and services | $72.36 | General |
| Category: Central Nervous System | ||||||
| 08/22/2024 | Teva Pharmaceuticals USA, Inc. | Austedo XR (Drug) | Food and Beverage | In-kind items and services | $15.31 | General |
| Category: Central Nervous System | ||||||
| 06/19/2024 | Teva Pharmaceuticals USA, Inc. | Austedo XR (Drug) | Food and Beverage | In-kind items and services | $14.59 | General |
| Category: Central Nervous System | ||||||
| 06/05/2024 | Teva Pharmaceuticals USA, Inc. | Austedo XR (Drug) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $204.40 | General |
| Category: Central Nervous System | ||||||
| 05/09/2024 | Teva Pharmaceuticals USA, Inc. | Austedo XR (Drug) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $2,600.00 | General |
| Category: Central Nervous System | ||||||
| 05/09/2024 | Teva Pharmaceuticals USA, Inc. | Austedo XR (Drug) | Food and Beverage | In-kind items and services | $69.83 | General |
| Category: Central Nervous System | ||||||
| 04/16/2024 | Teva Pharmaceuticals USA, Inc. | — | Education | In-kind items and services | $111.49 | General |
| 03/16/2024 | Teva Pharmaceuticals USA, Inc. | Austedo XR (Drug) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $4,088.00 | General |
| Category: Central Nervous System | ||||||
| 03/16/2024 | Teva Pharmaceuticals USA, Inc. | Austedo XR (Drug) | Travel and Lodging | Cash or cash equivalent | $415.21 | General |
| Category: Central Nervous System | ||||||
| 03/16/2024 | Teva Pharmaceuticals USA, Inc. | Austedo XR (Drug) | Food and Beverage | In-kind items and services | $75.00 | General |
| Category: Central Nervous System | ||||||
| 03/16/2024 | Teva Pharmaceuticals USA, Inc. | Austedo XR (Drug) | Food and Beverage | In-kind items and services | $59.98 | General |
| Category: Central Nervous System | ||||||
| 03/16/2024 | Teva Pharmaceuticals USA, Inc. | Austedo XR (Drug) | Food and Beverage | In-kind items and services | $59.97 | General |
| Category: Central Nervous System | ||||||
| 03/16/2024 | Teva Pharmaceuticals USA, Inc. | Austedo XR (Drug) | Food and Beverage | In-kind items and services | $38.19 | General |
| Category: Central Nervous System | ||||||
| 03/16/2024 | Teva Pharmaceuticals USA, Inc. | Austedo XR (Drug) | Food and Beverage | In-kind items and services | $35.67 | General |
| Category: Central Nervous System | ||||||
| 03/16/2024 | Teva Pharmaceuticals USA, Inc. | Austedo XR (Drug) | Travel and Lodging | In-kind items and services | $35.05 | General |
| Category: Central Nervous System | ||||||
| 03/16/2024 | Teva Pharmaceuticals USA, Inc. | Austedo XR (Drug) | Food and Beverage | In-kind items and services | $16.22 | General |
| Category: Central Nervous System | ||||||
| 03/15/2024 | Teva Pharmaceuticals USA, Inc. | Austedo XR (Drug) | Travel and Lodging | In-kind items and services | $665.19 | General |
| Category: Central Nervous System | ||||||
| 03/15/2024 | Teva Pharmaceuticals USA, Inc. | Austedo XR (Drug) | Travel and Lodging | In-kind items and services | $233.40 | General |
| Category: Central Nervous System | ||||||
| 03/15/2024 | Teva Pharmaceuticals USA, Inc. | Austedo XR (Drug) | Travel and Lodging | In-kind items and services | $145.59 | General |
| Category: Central Nervous System | ||||||
| 01/17/2024 | Teva Pharmaceuticals USA, Inc. | Austedo XR (Drug) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $2,600.00 | General |
| Category: Central Nervous System | ||||||
| 01/17/2024 | Teva Pharmaceuticals USA, Inc. | Austedo XR (Drug) | Food and Beverage | In-kind items and services | $57.71 | General |
| Category: Central Nervous System | ||||||
| 11/05/2023 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $28.53 | General |
| Category: NEUROSCIENCE | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 11 | 815 | 2,360 | $244,065 | $125,774 |
| 2022 | 11 | 819 | 2,451 | $244,555 | $115,683 |
| 2021 | 10 | 850 | 2,522 | $255,555 | $120,662 |
| 2020 | 12 | 940 | 2,614 | $260,455 | $109,555 |
All Medicare Procedures & Services
46 procedure records from CMS Medicare Utilization — Page 1 of 2
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 307 | 1,029 | $93,800 | $45,945 | 49.0% |
| 99232 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 35 minutes | Facility | 2023 | 71 | 508 | $44,430 | $30,781 | 69.3% |
| 99231 | Subsequent hospital care with straightforward or low level of medical decision making, per day, if using time, at least 25 minutes | Facility | 2023 | 66 | 278 | $22,270 | $10,479 | 47.1% |
| 90834 | Psychotherapy, 45 minutes | Office | 2023 | 30 | 135 | $18,365 | $8,667 | 47.2% |
| 99222 | Initial hospital care with straightforward or low-level medical decision making, if using time, at least 55 minutes | Facility | 2023 | 75 | 76 | $16,070 | $7,101 | 44.2% |
| 99306 | Initial nursing facility care with high level of medical decision making, per day, if using time, at least 45 minutes | Office | 2023 | 34 | 76 | $9,635 | $6,596 | 68.5% |
| 99221 | Initial hospital care with straightforward or low level of medical decision making, per day, if using time, at least 40 minutes | Facility | 2023 | 66 | 76 | $13,395 | $4,821 | 36.0% |
| 99238 | Hospital discharge day management, 30 minutes or less | Facility | 2023 | 60 | 70 | $10,560 | $4,235 | 40.1% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 36 | 38 | $3,845 | $2,747 | 71.5% |
| 90791 | Psychiatric diagnostic evaluation | Office | 2023 | 30 | 30 | $6,000 | $2,314 | 38.6% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Facility | 2023 | 23 | 27 | $2,700 | $1,060 | 39.3% |
| 99304 | Initial nursing facility care with straightforward or low level of medical decision making, per day, if using time, at least 25 minutes | Office | 2023 | 17 | 17 | $2,995 | $1,027 | 34.3% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 371 | 1,168 | $105,120 | $47,383 | 45.1% |
| 99232 | Follow-up hospital inpatient care per day, typically 25 minutes | Facility | 2022 | 66 | 393 | $33,405 | $21,542 | 64.5% |
| 99231 | Follow-up hospital inpatient care per day, typically 15 minutes | Facility | 2022 | 88 | 434 | $34,720 | $12,962 | 37.3% |
| 90834 | Psychotherapy, 45 minutes | Office | 2022 | 29 | 127 | $17,145 | $8,305 | 48.4% |
| 99222 | Initial hospital inpatient care per day, typically 50 minutes | Facility | 2022 | 67 | 67 | $14,070 | $6,835 | 48.6% |
| 99221 | Initial hospital inpatient care per day, typically 30 minutes | Facility | 2022 | 48 | 69 | $12,075 | $5,259 | 43.5% |
| 90791 | Psychiatric diagnostic evaluation | Office | 2022 | 35 | 35 | $7,000 | $4,153 | 59.3% |
| 99238 | Hospital discharge day management, 30 minutes or less | Facility | 2022 | 58 | 73 | $10,950 | $3,992 | 36.5% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 31 | 44 | $4,400 | $2,809 | 63.8% |
| 99219 | Initial hospital observation care per day, typically 50 minutes | Facility | 2022 | 13 | 13 | $2,730 | $1,316 | 48.2% |
| 90832 | Psychotherapy, 30 minutes | Office | 2022 | 13 | 28 | $2,940 | $1,126 | 38.3% |
| 99213 | Established patient outpatient visit, total time 20-29 minutes | Office | 2021 | 420 | 1,337 | $119,745 | $54,820 | 45.8% |
| 99232 | Subsequent hospital inpatient care, typically 25 minutes per day | Facility | 2021 | 55 | 317 | $26,945 | $17,633 | 65.4% |
About Dr. Ahmed Faheem, MD
Dr. Ahmed Faheem, MD is a Psychiatry healthcare provider based in Beckley, West Virginia. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 10/31/2006. The National Provider Identifier (NPI) number assigned to this provider is 1649356866.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Ahmed Faheem, MD has received a total of $122,820 in payments from pharmaceutical and medical device companies, with $14,301 received in 2024. These payments were reported across 262 transactions from 8 companies. The most common payment nature is "Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program" ($110,705).
As a Medicare-enrolled provider, Faheem has provided services to 3,424 Medicare beneficiaries, totaling 9,947 services with total Medicare billing of $471,674. Data is available for 4 years (2020–2023), covering 46 distinct procedure/service records.
Practice Information
- Specialty Psychiatry
- Other Specialties Addiction Psychiatry, Child & Adolescent Psychiatry
- Location Beckley, WV
- Active Since 10/31/2006
- Last Updated 04/18/2011
- Taxonomy Code 2084P0800X
- Entity Type Individual
- NPI Number 1649356866
Products in Payments
- AUSTEDO (Drug) $46,370
- LATUDA (Drug) $28,719
- VRAYLAR (Drug) $24,180
- Austedo XR (Drug) $19,454
- Acuvue (Device) $111.72
- NAMZARIC (Drug) $23.44
- TRAVATAN Z (Drug) $18.44
- ABILIFY MAINTENA (Drug) $16.97
- VIIBRYD (Drug) $15.78
- QELBREE (Drug) $11.32
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Psychiatry Doctors in Beckley
Dr. Omar Hasan, Md, MD
Psychiatry — Payments: $44,378
Hassan Jafary, Md, MD
Psychiatry — Payments: $17,454
Dr. Jawad Zafar, D.o, D.O
Psychiatry — Payments: $8,608
Michelle Bez, Pa-C, PA-C
Psychiatry — Payments: $4,373
Dr. Brandon Workman, D.o, D.O
Psychiatry — Payments: $3,431
Dr. Safiullah Syed, Md, MD
Psychiatry — Payments: $1,155